Neoplasms, Muscle Tissue  >>  Mifeprex (mifepristone)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mifeprex (mifepristone) / Danco Laboratories
NCT00133705: Trial of Mifepristone for Fibroids

Completed
3
70
US
Mifepristone, RU486, Inert Capsule
University of Rochester, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Leiomyoma
06/10
06/10
Mifemyo, NCT00712595: Mifepristone for Treatment of Uterine Fibroids

Checkmark
Sep 2013 - Sep 2013: 
Completed
2/3
200
RoW
Mifepristone, Low doses of antiprogestins to treat uterine fibroids.
Mediterranea Medica S. L.
Uterine Fibroids
01/07
03/09
Mifemyo_2, NCT00886873: Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids

Completed
2/3
100
RoW
Mifepristone
Mediterranea Medica S. L.
Uterine Fibroids
04/09
05/09
NCT01786226: Mifepristone to Treat Uterine Fibroids

Checkmark
Aug 2013 - Aug 2013: 
Terminated
2/3
220
RoW
Oral administration of mifepristone 2.5 mg daily for three months, Low doses of antiprogestins to treat uterine fibroids, Oral administration of mifepristone 5 mg daily for three months
Mediterranea Medica S. L.
Uterine Fibroids
03/12
03/12

Download Options